Brian Porter

5.0k citations
91 papers · 3.6k · 1 hit paper · h-index 32

Impact in

  • Rheumatology top 0.2%
    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
  • Immunology top 1%
    • Psoriasis: Treatment and Pathogenesis
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology

Papers in

    • Spondyloarthritis Studies and Treatments 54
    • Rheumatoid Arthritis Research and Therapies 43
    • Systemic Lupus Erythematosus Research 6
    • Psoriasis: Treatment and Pathogenesis 28
    • Immune Cell Function and Interaction 8
    • T-cell and B-cell Immunology 7

Brian Porter

90 papers receiving 3.6k citations

Brian Porter's Hit Papers

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis 2015 · 732 citations
7320+3+7Years since publication200400600

Peers

Brian Porter
Comparison fields: 5 of 114
  • Rheumatology 2.0k
  • Immunology 2.1k
  • Hematology 999
  • Virology 143
  • Dermatology 186
Replace Christian M. Hedrich with:
Christian M. Hedrich Germany
Elliot Chartash United States
Ori Elkayam Israel
Bruce Freundlich United States
José Luís Andreu Spain
Denis Mulleman France
Michael Frosch Germany
Muhammad Asim Khan United States
Anja Strangfeld Germany
Imad Uthman Lebanon
Brian Porter relative to Christian M. Hedrich Germany Christian M. Hedrich's profile →
Citations per field
00.5×6.2×
Christian M. Hedrich · 1×
Citations per year

Countries citing papers authored by Brian Porter

Since Specialization
Citations

This map shows the geographic impact of Brian Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Porter more than expected).

Fields of papers citing papers by Brian Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Porter. The network helps show where Brian Porter may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian Porter Line = papers co-authored together Brian Porter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Hit paper breakdown →
2015732
2 2019215
3 2017162
4 2010142
5 2019139
6 2016130
7 2000127
8 2020113
9 2018108
10 2018106
11 201492
12 201883
13 201377
14 201776
15
Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial.
201769
16 201166
17 201664
18 199952
19 199948
20
IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of gammac-/- mice: roles for both IL-2 and IL-15 in CD8alphaalpha IEL development.
199941

About Brian Porter

Brian Porter is a scholar working on Rheumatology, Immunology, Hematology, Epidemiology and Surgery, having authored 91 papers that have together received 3.6k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (54 papers), Rheumatoid Arthritis Research and Therapies (43 papers), Psoriasis: Treatment and Pathogenesis (28 papers), Autoimmune and Inflammatory Disorders Research (21 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (7 papers), Infectious Diseases and Tuberculosis (7 papers) and Systemic Lupus Erythematosus Research (6 papers). The work is most often cited by research in Rheumatology (2.0k citations), Immunology (2.1k citations), Hematology (999 citations), Virology (143 citations) and Dermatology (186 citations). Brian Porter has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Atul Deodhar, Thomas R. Malek, Xenofon Baraliakos, Hanno B. Richards, Jürgen Braun, Mats Andersson, Joachim Sieper, Ruvie Martin, Paul Emery and Dominique Baeten. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, AIDS, Arthritis Research & Therapy and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact